Show
Sort by
-
Validation of postinduction Curie scores in high-risk neuroblastoma : a Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1
-
Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations : the SIOPEN/HR-NBL1 and COG-A3973 trials
-
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia : results of the EORTC CLG 58881 and 58951 trials
-
Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study
-
- Journal Article
- A1
- open access
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection
-
Surrogate marker analysis in cancer clinical trials through time-to-event mediation techniques
-
Ibrutinib as initial therapy for patients with chronic lymphocytic leukemia
-
Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells
-
- Journal Article
- A1
- open access
Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines : randomized, double-blind study in malaria-naïve adults
-
Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results